RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000084.xml
Synthesis 2013; 45(17): 2413-2416
DOI: 10.1055/s-0033-1339325
DOI: 10.1055/s-0033-1339325
paper
5,6,7,8-Tetrahydropyrido[4,3-c]pyridazine: A Lead-Oriented Scaffold with Two Diversity Points
Weitere Informationen
Publikationsverlauf
Received: 17. April 2013
Accepted after revision: 07. Juni 2013
Publikationsdatum:
10. Juli 2013 (online)
![](https://www.thieme-connect.de/media/synthesis/201317/lookinside/thumbnails/10.1055-s-0033-1339325-1.jpg)
Abstract
An approach to the derivatives of 5,6,7,8-tetrahydropyrido[4,3-c]pyridazine, a lead-oriented scaffold with two diversity points, was developed. The method included five steps starting from the readily available 4-piperidone derivatives and allowed for the preparation of the target compounds in 32–35% overall yields. The key step of the sequence included one-pot solvent-free reaction of the corresponding 4-piperidone derivative, glyoxylic acid, and hydrazine.
Key words
nitrogen heterocycles - pyridazine - piperidine - nucleophilic substitution - lead-oriented synthesisSupporting Information
- for this article is available online at http://www.thieme-connect.com/ejournals/toc/synthesis.
- Supporting Information
-
References
- 1a Heinisch G, Frank H. Prog. Med. Chem. 1990; 27: 1
- 1b Heinisch G, Kopelent-Frank H. Prog. Med. Chem. 1992; 29: 141
- 2 Wermuth CG. Med. Chem. Commun. 2011; 2: 935
- 3a Olsen AG, Dahl O, Nielsen PE. Bioorg. Med. Chem. Lett. 2004; 14: 1551
- 3b Malnuit V, Duca M, Benhida R. Org. Biomol. Chem. 2011; 9: 326
- 4 Volonterio A, Moisan L, Rebek JJr. Org. Lett. 2007; 9: 3733
- 5a Lovering F, Bikker J, Humblet C. J. Med. Chem. 2009; 52: 6752
- 5b Nicholls A, McGaughey GB, Sheridan RP, Good AC, Warren G, Mathieu M, Muchmore SW, Brown SP, Grant JA, Haigh JA, Nevins N, Jain AN, Kelley B. J. Med. Chem. 2010; 53: 3862
- 6 Instant JChem was used for prediction of the physico-chemical properties of 1: Instant JChem 3.0, 2009, ChemAxon (http://www.chemaxon.com).
- 7 Congreve M, Carr R, Murray C, Jhoti H. Drug Discovery Today 2003; 8: 876
- 8 Grygorenko OO, Radchenko DS, Volochnyuk DM, Tolmachev AA, Komarov IV. Chem. Rev. 2011; 111: 5506
- 9 Nadin A, Hattotuwagama C, Churcher I. Angew. Chem. Int. Ed. 2012; 51: 1114
- 10 Salzmann R, Bürki H, Chu D, Clark B, Marbach P, Markstein R, Reinert H, Siegl H, Waite R. Arzneim.-Forsch. 1979; 29: 1843
- 11 Schenker E, Salzmann R. Arzneim.-Forsch. 1979; 29: 1835
- 12a Kozikowski AP, Park P. J. Org. Chem. 1990; 55: 4668
- 12b Masse J, Langlois N. Heterocycles 2009; 77: 417
- 13 Suzuki K, Senoh A, Ueno K. Heterocycles 2002; 57: 723